🔎 Trials Near Me

Home › COPD › Florida › Tampa

COPD clinical trials in Tampa, FL

7 studies for COPD are looking for participants at sites in and around Tampa (within about 30 miles). Open a study to see who can join and how to contact the study team.

A Study to Investigate the Efficacy and Safety of GSK5784283 (Felcorekibart) Compared With Placebo in Participants With Moderate to Very Severe COPD (PERSIST COPD-2)

RecruitingPhase 3
  • GSK Investigational Site, Tampa
Ages 40 to 80 · All sexes · Updated Sep 25, 2026 · NCT07780656

Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD) Characterized by an Eosinophilic Phenotype

RecruitingPhase 3
  • Clinical Research Trials of Florida- Site Number : 8400011, Tampa
  • Deluxe Health Center-Tampa- Site Number : 8400056, Tampa
Ages 40 to 80 · All sexes · Updated Sep 22, 2026 · NCT07190209

A Study to Investigate the Effect of AZD6793 in Participants With Moderate to Very Severe Chronic Obstructive Pulmonary Disease

RecruitingPhase 2
  • Research Site, Tampa
  • Research Site, Tampa
Ages 40 and older · All sexes · Updated Sep 9, 2026 · NCT07082738

A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00006)

RecruitingPhase 3
  • Research Site, Tampa
  • Research Site, Tampa
Ages 40 to 80 · All sexes · Updated Sep 3, 2026 · NCT06883305

A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate to Severe Chronic Obstructive Pulmonary Disease

RecruitingPhase 2/3
  • Clinical Research Trials of Florida, Inc., Tampa
Ages 35 to 80 · All sexes · Updated Aug 31, 2026 · NCT07363694

About COPD

COPD (chronic obstructive pulmonary disease) makes it hard for you to breathe. At first symptoms are mild, but they usually become more severe. Learn more.

More about COPD on MedlinePlus

COPD trials in other cities

Other studies in Tampa

From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.